Gastrointestinal tolerability of nimesulide, a selective cyclooxygenase-2 inhibitor, in experimental animals and man

Author： Sigthorsson Gudmundur Thjodleifsson Bjarni Mahmud Taher Bjarnason Ingvar

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.8, Iss.2, 2000-06, pp. : 175-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the selective cyclooxygenase-2 inhibitor nimesulide on vascular contractions in endothelium-denuded rat aorta

By Connolly C. McCormick P.A. Docherty J.R.

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats

By Cuzzocrea S. Mazzon E. Serraino I. Dugo L. Centorrino T. Ciccolo A. Sautebin L. Caputi A.P.

European Journal of Pharmacology, Vol. 431, Iss. 1, 2001-11 ,pp. : 91-102

Elsevier

Access to resources Recommend Favorite

Selective cyclooxygenase-2 inhibitor induces gastric mucosal damage in adrenalectomized rats

By Filaretova L. Tanaka A. Komoike Y. Takeuchi K.

Inflammopharmacology, Vol. 10, Iss. 4-6, 2002-12 ,pp. : 413-422

VSP

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib: A Selective Cyclo-Oxygenase-2 Inhibitor

By Davies N.M.

Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. : 225-242

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology of Lumiracoxib: A Selective Cyclo-Oxygenase-2 Inhibitor

By Rordorf Christiane M.

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1247-1266

Adis International

Access to resources Recommend Favorite